Science and Research

MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis

The hormone relaxin is considered a potential therapy for idiopathic pulmonary fibrosis (IPF). We have previously shown that a potential limitation to relaxin-based IPF therapy is decreased expression of a relaxin receptor, relaxin/insulin-like family peptide receptor 1 (RXFP1), in IPF fibroblasts. The mechanism that down-regulates RXFP1 in IPF remains unclear. To determine whether microRNAs (miRs) regulate RXFP1 gene expression, here we employed a bioinformatics approach to identify miRs predicted to target RXFP1 and identified a putative miR-144-3p target site in the RXFP1 mRNA. In situ hybridization of IPF lung biopsies revealed that miR-144-3p is expressed in fibroblastic foci. Furthermore, we found that miR-144-3p is up-regulated in IPF fibroblasts compared with lung fibroblasts from healthy donors. Transforming growth factor beta increased miR-144-3p expression in both healthy and IPF lung fibroblasts in a SMAD family 2/3 (SMAD2/3)-dependent manner, and Jun proto-oncogene AP-1 transcription factor subunit (AP-1) was required for constitutive miR-144-3p expression. Overexpression of an miR-144-3p mimic significantly reduced RXFP1 mRNA and protein levels and increased expression of the myofibroblast marker alpha-smooth muscle actin (alpha-SMA) in healthy lung fibroblasts. IPF lung fibroblasts transfected with anti-miR-144-3p had increased RXFP1 expression and reduced alpha-SMA expression. Of note, a lentiviral luciferase reporter carrying the WT 3' UTR of RXFP1 was significantly repressed in IPF lung fibroblasts, whereas a reporter carrying a mutated miR-144-3p-binding site exhibited less sensitivity toward endogenous miR-144-3p expression, indicating that miR-144-3p down-regulates RXFP1 in IPF lung fibroblasts by targeting its 3' UTR. We conclude that miR-144-3p directly represses RXFP1 mRNA and protein expression.

  • Bahudhanapati, H.
  • Tan, J.
  • Dutta, J. A.
  • Strock, S. B.
  • Sembrat, J.
  • Alvarez, D.
  • Rojas, M.
  • Jager, B.
  • Prasse, A.
  • Zhang, Y.
  • Kass, D. J.

Keywords

  • 3' Untranslated Regions
  • Cells, Cultured
  • Fibroblasts/metabolism/*pathology
  • Gene Expression Regulation
  • Humans
  • Idiopathic Pulmonary Fibrosis/epidemiology/*genetics/pathology
  • Lung/metabolism/*pathology
  • MicroRNAs/*genetics
  • RNA, Messenger/genetics
  • Receptors, G-Protein-Coupled/*genetics
  • Receptors, Peptide/*genetics
  • *epigenetics
  • *fibroblast
  • *idiopathic pulmonary fibrosis
  • *lung disease
  • *lung fibroblasts
  • *miR-144-3p
  • *microRNA (miRNA)
  • *myofibroblast
  • *post-transcriptional regulation
  • *pulmonary fibrosis
  • *relaxin
  • *relaxin/insulin-like family peptide receptor 1 (RXFP1)
  • *transforming growth factor beta (TGF-B)
Publication details
DOI: 10.1074/jbc.RA118.004910
Journal: J Biol Chem
Pages: 5008-5022 
Number: 13
Work Type: Original
Location: BREATH
Disease Area: DPLD
Partner / Member: ITEM, MHH
Access-Number: 30709904
See publication on PubMed

DZL Engagements

chevron-down